Drug Type Small molecule drug |
Synonyms Penicillin G procaine (USP), Duracillin, PFIZERPEN-AS + [1] |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (26 Apr 1948), |
Regulation- |
Molecular FormulaC29H38N4O6S |
InChIKeyWHRVRSCEWKLAHX-LQDWTQKMSA-N |
CAS Registry54-35-3 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D02461 | Penicillin G Procaine |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Gingivitis | Australia | 04 Aug 2017 | |
| Gonorrhea | Australia | 04 Aug 2017 | |
| Pharyngitis | Australia | 04 Aug 2017 | |
| Pneumococcal Infections | Australia | 04 Aug 2017 | |
| Respiratory Tract Infections | Australia | 04 Aug 2017 | |
| Scarlet Fever | Australia | 04 Aug 2017 | |
| Skin and skin structure infections | Australia | 04 Aug 2017 | |
| Staphylococcal Infections | Australia | 04 Aug 2017 | |
| Streptococcal Infections | Australia | 04 Aug 2017 | |
| Syphilis | Australia | 04 Aug 2017 | |
| Bacterial Infections | United States | 26 Apr 1948 |





